Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CN Stock MarketDetailed Quotes
C.Q. Pharmaceutical Holding (000950)
- 5.87
- -0.02-0.34%
Trading Apr 27 10:36 CST
10.14BMarket Cap23.48P/E (TTM)
5.90High5.79Low179.92KlotVolume5.83Open5.89Prev Close105.23MTurnover1.04%Turnover Ratio26.21P/E (Static)1.73BShares7.4152wk High0.87P/B10.14BFloat Cap4.8052wk Low6.48Limit Up1.73BShs Float14.65Historical High5.30Limit Down1.87%Range %-0.06Historical Low0.06Dividend TTM5.85Avg Price91.37KlotAsk1.02%Div Yield TTM100Lot Size87.03KlotBid
C.Q. Pharmaceutical Holding (000950) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.63%20.2B | 2.28%92.16B | 0.74%65.6B | 1.83%42.66B | -1.07%20.32B | 10.20%90.1B | 6.80%65.12B | 8.23%41.89B | 14.71%20.54B | 11.46%81.76B |
| Refunds of taxes and levies | ---- | --0 | ---- | ---- | ---- | 742.40%19.16M | 186.34%6.78M | 256.44%2.38M | 1,184.63%2.36M | -86.62%2.27M |
| Cash received relating to other operating activities | -5.50%413.64M | 116.69%2.44B | 51.91%1.39B | 278.50%1.64B | 689.00%437.74M | -39.29%1.13B | 84.82%913.63M | 3.80%432.27M | -77.11%55.48M | -3.42%1.85B |
| Cash inflows from operating activities | -0.73%20.61B | 3.67%94.6B | 1.43%66.99B | 4.65%44.3B | 0.78%20.76B | 9.12%91.25B | 7.43%66.04B | 8.19%42.33B | 13.50%20.6B | 11.06%83.62B |
| Goods services cash paid | 4.24%21.96B | 1.27%86.08B | -1.23%64.05B | -1.92%42.45B | -6.27%21.07B | 11.41%85B | 7.23%64.84B | 6.88%43.28B | 11.64%22.47B | 10.40%76.29B |
| Staff behalf paid | -15.14%551.08M | -5.92%1.88B | -8.54%1.44B | -13.45%951.19M | 1.16%649.38M | 1.72%2B | 16.49%1.57B | 23.26%1.1B | 32.01%641.92M | 7.42%1.97B |
| All taxes paid | 48.42%480.35M | 6.37%1.55B | -8.06%1.04B | -5.37%723.81M | -17.67%323.65M | -17.11%1.46B | -3.81%1.13B | -3.70%764.9M | 6.01%393.13M | 25.44%1.76B |
| Cash paid relating to other operating activities | 5.40%935.96M | 45.68%4.33B | 69.81%2.8B | 190.01%2.44B | 264.80%888.01M | -3.86%2.97B | 13.84%1.65B | 10.60%842.17M | -5.07%243.43M | 15.93%3.09B |
| Cash outflows from operating activities | 4.36%23.93B | 2.63%93.84B | 0.18%69.32B | 1.26%46.57B | -3.48%22.93B | 10.01%91.43B | 7.37%69.19B | 7.09%45.99B | 11.80%23.75B | 10.81%83.11B |
| Net cash flows from operating activities | -53.20%-3.32B | 504.14%754.67M | 26.03%-2.33B | 37.87%-2.27B | 31.31%-2.16B | -136.72%-186.74M | -6.18%-3.15B | 4.13%-3.66B | -1.86%-3.15B | 77.92%508.53M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | 279.16%339.42M | --74.65M | ---- | ---- | 30.70%89.52M | ---- | --0 | ---- | -59.75%68.49M |
| Cash received from returns on investments | ---- | 24.13%119.04M | 29.03%119.04M | 38.59%119.04M | ---- | 50.41%95.9M | 44.52%92.26M | 44.10%85.89M | ---- | 35.40%63.76M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 262.57%82.31K | -27.61%1.01M | -49.29%701.01K | -66.52%235.48K | -94.76%22.7K | 69.23%1.4M | -58.43%1.38M | -74.49%703.38K | 50,301.69%433.45K | -87.48%825.5K |
| Net cash received from disposal of subsidiaries and other business units | ---- | --399.61K | --399.61K | --399.61K | --399.61K | --0 | ---- | --0 | --0 | -95.39%3.77M |
| Cash received relating to other investing activities | 1,165.40%13.65M | -25.49%58.45M | -29.23%40.45M | -61.12%19.76M | -93.75%1.08M | 832.02%78.45M | 898.31%57.15M | 1,313.94%50.82M | -67.15%17.26M | --8.42M |
| Cash inflows from investing activities | 814.91%13.73M | 95.40%518.32M | 56.00%235.24M | 1.47%139.43M | -91.51%1.5M | 82.60%265.25M | 16.23%150.79M | 11.90%137.41M | -83.87%17.69M | -52.48%145.26M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 24.26%99.83M | 19.56%299.54M | 38.97%206.62M | 49.64%130.92M | 67.65%80.34M | 2.51%250.53M | 18.57%148.68M | -0.30%87.49M | -3.02%47.92M | -8.83%244.41M |
| Cash paid to acquire investments | ---- | --0 | ---- | --0 | ---- | --48.48M | --41.5M | --41.5M | --340K | --0 |
| Net cash paid to acquire subsidiaries and other business units | ---- | -81.78%25.2M | -81.67%25.2M | -74.74%23.14M | 51.01%21.99M | -26.31%138.36M | -2.64%137.51M | -33.79%91.61M | --14.56M | -17.24%187.75M |
| Impawned loan net increase | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | ---- | 188.11%29.82M | 902.66%65.17M | 7,481.65%30.37M | 900.44%5M | -85.52%10.35M | -91.33%6.5M | -98.47%400.58K | -98.09%500K | --71.49M |
| Cash outflows from investing activities | -6.99%99.83M | -20.81%354.57M | -11.13%297M | -16.55%184.43M | 69.50%107.33M | -11.10%447.72M | -2.16%334.19M | -12.39%221M | -16.26%63.32M | 1.35%503.65M |
| Net cash flows from investing activities | 18.65%-86.1M | 189.74%163.75M | 66.32%-61.76M | 46.17%-45M | -131.93%-105.83M | 49.09%-182.46M | 13.43%-183.4M | 35.43%-83.59M | -233.90%-45.63M | -87.40%-358.38M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | -77.29%238.71M | 12.84%32.32M | -24.12%19.03M | 38.21%12.35M | -53.72%1.05B | -88.54%28.64M | -89.73%25.08M | -74.16%8.93M | 14,476.63%2.27B |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | -77.29%238.71M | 12.84%32.32M | -24.12%19.03M | 38.21%12.35M | -53.72%1.05B | -88.54%28.64M | -89.73%25.08M | -74.16%8.93M | 14,476.63%2.27B |
| Cash from borrowing | 22.64%6.03B | 4.08%24.75B | -10.34%17.57B | -20.87%11.48B | -14.41%4.91B | -4.46%23.78B | -3.79%19.6B | 5.70%14.51B | -16.96%5.74B | 3.46%24.89B |
| Cash received relating to other financing activities | -23.55%200.28M | -46.99%392.2M | 8.59%362.07M | 22.84%281.45M | 153.41%261.98M | -40.80%739.81M | -32.18%333.42M | -13.62%229.13M | 556.62%103.38M | 84.44%1.25B |
| Cash inflows from financing activities | 20.02%6.23B | -0.74%25.38B | -9.99%17.97B | -20.20%11.78B | -11.37%5.19B | -9.99%25.57B | -5.46%19.96B | 3.71%14.77B | -15.95%5.85B | 14.78%28.41B |
| Borrowing repayment | -25.10%3.66B | 5.29%24.11B | -0.17%17.21B | -6.80%11.23B | -16.74%4.89B | -11.02%22.9B | -2.05%17.24B | 17.32%12.05B | 10.59%5.87B | 28.54%25.74B |
| Dividend interest payment | -6.84%218.37M | -18.21%1.17B | -16.64%903.34M | -18.53%551.5M | -11.86%234.42M | 0.16%1.43B | 8.06%1.08B | 20.59%676.97M | -7.42%265.95M | 33.86%1.43B |
| -Including:Cash payments for dividends or profit to minority shareholders | 118.45%7.19M | -4.54%297.14M | -24.06%180.69M | -39.17%46.38M | -45.96%3.29M | 139.45%311.28M | 184.30%237.95M | 49.05%76.23M | --6.09M | -6.32%130M |
| Cash payments relating to other financing activities | -23.34%169.19M | -11.62%1.05B | -9.69%526.16M | -8.54%326.25M | 68.78%220.71M | 19.96%1.19B | 26.17%582.63M | 32.71%356.72M | 268.07%130.77M | -59.99%993.57M |
| Cash outflows from financing activities | -24.22%4.05B | 3.18%26.34B | -1.41%18.64B | -7.45%12.11B | -14.75%5.35B | -9.36%25.53B | -0.83%18.9B | 17.85%13.09B | 11.30%6.27B | 19.46%28.16B |
| Net cash flows from financing activities | 1,483.64%2.18B | -2,074.66%-954.43M | -163.11%-668.38M | -119.46%-327.15M | 62.25%-157.31M | -80.86%48.33M | -48.40%1.06B | -46.40%1.68B | -131.31%-416.72M | -78.60%252.49M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | 49.51%-1.23B | 88.78%-36.02M | -34.55%-3.06B | -28.31%-2.65B | 32.82%-2.43B | -179.69%-320.87M | -102.01%-2.27B | -154.42%-2.06B | -109.03%-3.61B | -68.41%402.64M |
| Add:Begin period cash and cash equivalents | -0.75%4.75B | -6.28%4.79B | -6.28%4.79B | -6.28%4.79B | -6.28%4.79B | 8.56%5.11B | 8.56%5.11B | 8.56%5.11B | 8.56%5.11B | 37.15%4.71B |
| End period cash equivalent | 49.42%3.53B | -0.75%4.75B | -39.06%1.73B | -29.70%2.14B | 57.90%2.36B | -6.28%4.79B | -20.84%2.83B | -21.80%3.05B | -49.80%1.49B | 8.56%5.11B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | PwC China (Special General Partnership) | -- | -- | -- | Tianzhi International Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianzhi International Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm